Literature DB >> 20036934

Molecular and functional genetics of hepatocellular carcinoma.

Judy Wai Ping Yam1, Chun Ming Wong, Irene Oi-Lin Ng.   

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer and one of the leading causes of cancer death worldwide. Hepatocarcinogenesis is a multistep process developing from normal through chronic hepatitis/cirrhosis and dysplastic nodules to HCC. Although we have insufficient understanding to propose a robust general model, with advances in molecular methods, there is a growing understanding of the molecular mechanisms in the development of HCC. Hepatocarcinogenesis is strongly linked to increases in allelic losses, chromosomal changes, gene mutations, epigenetic alterations, and alterations in molecular cellular pathways. Special emphasis in this review is given to the genetics, epigenetics, and regulation of major signaling pathways involved in HCC such as Wnt/b-catenin, Ras, and PI3K/Akt/mTOR pathways. A detailed understanding of the underlying molecular mechanisms involved in the progression of HCC can improve our prevention and diagnostic tools for HCC and be an important potential source of novel molecular targets for new therapies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20036934     DOI: 10.2741/s51

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  12 in total

1.  Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies.

Authors:  James P Hamilton
Journal:  Epigenomics       Date:  2010-04-01       Impact factor: 4.778

2.  Chronic ingestion of ethanol induces hepatocellular carcinoma in mice without additional hepatic insult.

Authors:  Mutsumi Tsuchishima; Joseph George; Hisakazu Shiroeda; Tomiyasu Arisawa; Tsutomu Takegami; Mikihiro Tsutsumi
Journal:  Dig Dis Sci       Date:  2013-01-31       Impact factor: 3.199

3.  Expression of Wnt-5a and β-catenin in primary hepatocellular carcinoma.

Authors:  Peifeng Li; Yongcheng Cao; Yamin Li; Luting Zhou; Xiaohong Liu; Ming Geng
Journal:  Int J Clin Exp Pathol       Date:  2014-05-25

4.  Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk.

Authors:  Long Lv; Ping Wang; Xiaoqing Zhou; Beicheng Sun
Journal:  Tumour Biol       Date:  2013-04-06

5.  TALEN-mediated somatic mutagenesis in murine models of cancer.

Authors:  Shuyuan Zhang; Lin Li; Sara L Kendrick; Robert D Gerard; Hao Zhu
Journal:  Cancer Res       Date:  2014-07-28       Impact factor: 12.701

6.  Immunohistochemical analysis of ezrin-radixin-moesin-binding phosphoprotein 50 in prostatic adenocarcinoma.

Authors:  Tanner L Bartholow; Michael J Becich; Uma R Chandran; Anil V Parwani
Journal:  BMC Urol       Date:  2011-06-14       Impact factor: 2.264

7.  Effects of STAT3 gene silencing and rapamycin on apoptosis in hepatocarcinoma cells.

Authors:  Yi Zhang; Jun-Wei Zhang; Guo-Yue Lv; Shu-Li Xie; Guang-Yi Wang
Journal:  Int J Med Sci       Date:  2012-03-07       Impact factor: 3.738

Review 8.  Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review).

Authors:  Drazen B Zimonjic; Nicholas C Popescu
Journal:  Int J Oncol       Date:  2012-05-10       Impact factor: 5.650

Review 9.  The role of p21-activated kinases in hepatocellular carcinoma metastasis.

Authors:  Edith Yuk Ting Tse; Yick Pang Ching
Journal:  J Mol Signal       Date:  2014-08-01

10.  Decreased expression of Sushi Domain Containing 2 correlates to progressive features in patients with hepatocellular carcinoma.

Authors:  Xin-Rui Liu; Cui-Xia Cai; Li-Min Luo; Wen-Ling Zheng; Rong Shi; Jun Zeng; You-Qin Xu; Min Wei; Wen-Li Ma
Journal:  Cancer Cell Int       Date:  2016-02-29       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.